Description:
Abalam is a fixed-dose combination antiretroviral therapy containing abacavir and lamivudine, designed to manage and suppress HIV-1 infection. This combination inhibits viral reverse transcriptase, effectively reducing viral load and increasing CD4 cell counts.
Abalam is suitable for adults and adolescents as part of a complete antiretroviral regimen. Its once-daily dosing, good tolerability, and proven efficacy have made it a cornerstone in HIV treatment. Abalam also carries the advantage of minimal drug interactions and is particularly important in patients where alternative regimens may be contraindicated.
Share your experience with our medical product. Write a review!
17 Nov 2025
Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
17 Nov 2025
The Role of Lifestyle Modifications in Chronic Disease Prevention
Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”
29 Sep 2025
Gut Health and Immunity: Why a Healthy Digestive System is Your First Line of Defense
When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.
29 Sep 2025
The Future of Pain Relief: From Traditional Balms to Next-Gen Transdermal Patches
Pain is one of the most common reasons people seek medical attention, whether it’s muscle pain after a long day, joint pain due to arthritis, or chronic conditions that affect daily living.
